Van Dam D

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer's disease - Van Dam_2008_Psychopharmacology.(Berl)_197_37
Author(s) : Van Dam D , Coen K , De Deyn PP
Ref : Psychopharmacology (Berl) , 197 :37 , 2008
Abstract : Van Dam_2008_Psychopharmacology.(Berl)_197_37
ESTHER : Van Dam_2008_Psychopharmacology.(Berl)_197_37
PubMedSearch : Van Dam_2008_Psychopharmacology.(Berl)_197_37
PubMedID: 18008065

Title : Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model - Van Dam_2005_Psychopharmacology.(Berl)_180_177
Author(s) : Van Dam D , Abramowski D , Staufenbiel M , De Deyn PP
Ref : Psychopharmacology (Berl) , 180 :177 , 2005
Abstract : Van Dam_2005_Psychopharmacology.(Berl)_180_177
ESTHER : Van Dam_2005_Psychopharmacology.(Berl)_180_177
PubMedSearch : Van Dam_2005_Psychopharmacology.(Berl)_180_177
PubMedID: 15654502

Title : Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models - Van Dam_2005_Neurochem.Int_46_409
Author(s) : Van Dam D , Marescau B , Engelborghs S , Cremers T , Mulder J , Staufenbiel M , De Deyn PP
Ref : Neurochem Int , 46 :409 , 2005
Abstract : Van Dam_2005_Neurochem.Int_46_409
ESTHER : Van Dam_2005_Neurochem.Int_46_409
PubMedSearch : Van Dam_2005_Neurochem.Int_46_409
PubMedID: 15737439